High prevalence of triple‐negative tumors in an urban cancer center

Cancer - Tập 113 Số 3 - Trang 608-615 - 2008
Mary Jo Lund1,2,3,4,5, Eboneé N. Butler1,5, Harvey L. Bumpers6, Joel Okoli6, Monica Rizzo7,4, Nadjo Hatchett4, Victoria L. Green8, Otis W. Brawley1,2,3,4, Gabriela Oprea‐Ilies9,4, Sheryl G. A. Gabram7,4
1Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia
2Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia
3Department of Hematology/Oncology, Georgia Cancer Center for Excellence at Grady Health System, Emory University, Atlanta, Georgia
4Emory University Winship Cancer Institute, Atlanta, Georgia
5The first 2 authors contributed equally to this work
6Department of Surgery, Georgia Cancer Center for Excellence at Grady Health System, Morehouse School of Medicine, Atlanta, Georgia
7Department of Surgery, Georgia Cancer Center for Excellence at Grady Health System, Emory University, Atlanta, Georgia
8Department of Obstetrics/Gynecology, Georgia Cancer Center for Excellence at Grady Health System, Emory University, Atlanta, Georgia
9Department of Pathology, Georgia Cancer Center for Excellence at Grady Health System, Emory University, Atlanta, Georgia

Tóm tắt

AbstractBACKGROUND.A disparate proportion of breast cancer deaths occur among young women, those of African‐American (AA) ancestry, and particularly young AA women. Estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor‐2 (HER‐2) are key clinically informative biomarkers. The triple‐negative (ER‐/PR‐/HER‐2‐) tumor subgroup is intrinsically resistant to treatment and portends a poor prognosis. Age, race, and socioeconomic status have been associated with triple‐negative tumors (TNT). In the current study, the authors investigated breast cancer subgroups among patients in an urban cancer center serving a multiracial, low socioeconomic population.METHODS.This case series analyzed female invasive breast cancers diagnosed and/or treated between 2003 and 2004 in the AVON Comprehensive Breast Center at Grady Hospital in Atlanta, Georgia. Data were obtained from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program, and augmented by the hospital registry and pathology reports. Statistical analyses utilized frequency distributions and logistic regression.RESULTS.Of 190 breast cancers; 167 (88%) were diagnosed among AA and 23 (12%) were diagnosed among non‐AA women. The median age at diagnosis in the 2 groups was 58 years and 57 years, respectively. TNT prevalence was found to differ by race (29.3% among AA women and 13.0% among non‐AA women; P = .010). Differences persisted after adjustment for age and stage (odds ratio [OR] of 3.1; 95%confidence interval [95% CI], 0.8–11.6). The majority of recurrences (40.0%) occurred among women with TNT, who were also most likely to experience a fatal event (OR of 3.7; 95%CI, 1.1–13.0).CONCLUSIONS.Despite a similarity in their age at diagnosis, AA women in our urban cancer center presented with a higher prevalence of TNT and TNT was found to predict the poorest outcomes. Institutional interactive breast conferences and intervention/navigation programs could help to dispel breast cancer disparities and improve outcomes. Cancer 2008. © 2008 American Cancer Society.

Từ khóa


Tài liệu tham khảo

American Cancer Society, 2007, Cancer Facts and Figures 2007

Ries LAG, 2007, SEER Cancer Statistics Review, 1975–2004

10.1677/erc.0.0090183

10.1200/JCO.2006.06.5664

Breen N, 1999, The relationship of socio‐economic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute Black‐White Cancer Survival Study, Ethn Dis, 9, 111

10.1002/cncr.11411

10.1001/archinte.162.17.1985

10.1001/jama.1994.03520120057031

10.1016/0021-9681(82)90020-0

10.1023/A:1017994726207

10.1158/0008-5472.CAN-06-1927

10.1002/cncr.20279

10.1023/A:1015220420400

10.1002/cncr.10827

10.1007/s10549-005-0324-9

Lund MJ, 2007, Parity and disparity in first course treatment of invasive breast cancer, Breast Cancer Res Treat

LundMJ EleyJW BrawleyOW LiffJM CoatesRJ PorterPL.Racial differences in triple negative breast tumors among women in Atlanta. Oral presentation of abstract at: American Association of Cancer Researchers Annual Meeting Washington DC April1–5 2006. Abstract LB‐4.

10.1001/jama.295.21.2492

10.1073/pnas.0932692100

10.1073/pnas.191367098

10.1002/cncr.22998

10.1002/cncr.22618

10.1007/s10549-007-9632-6

Fritz A, 2000, International Classification of Diseases for Oncology

10.1007/978-1-4757-3656-4

Carrizosa DR, 2005, Adjuvant systemic therapy in young women, Breast Dis, 23, 67, 10.3233/BD-2006-23109

10.1093/jnci/djj223

OlopadeOI IkpattFO DignamJJ et al.“Intrinsic gene expression” subtypes correlated with grade and morphometric parameters reveal a high proportion of aggressive basal‐like tumors among black women of African ancestry. Presented at: American Society of Clinical Oncology Annual Meeting New Orleans Louisiana June2004.

Birnbaum D, 2004, Basal and luminal breast cancers: basic or luminous? [review], Int J Oncol, 25, 249

10.4161/cc.5.9.2713

10.1016/j.molmed.2006.09.004

10.1186/1471-2164-7-127

10.1073/pnas.1732912100

10.1158/1055-9965.EPI-06-0806

10.1038/35021093

National Comprehensive Cancer Network (NCCN), 2006, Clinical Practice Guidelines in Oncology. Version 1

10.1056/NEJMoa052122

10.1186/bcr1639

10.1007/s10549-006-9346-1

Thông tin
Thông tin xuất bản

Cancer

Tập 113 Số 3

608-615

Thông tin tác giả